Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 21, Issue 16, 2015, Pages 4954-4960

  Hwang, Jae Jin ^a   Lee, Dong Ho ^a   Lee, Ae Ra ^a   Yoon, Hyuk ^a   Shin, Cheol Min ^a   Park, Young Soo ^a   Kim, Nayoung ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Duodenal ulcer; Eradication therapy; Gastric cancer; Gastric ulcer; Helicobacter pylori

Indexed keywords

PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CLINICAL FEATURE; DUODENUM ULCER; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; STOMACH CANCER; STOMACH ULCER; AGED; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INCIDENCE; ISOLATION AND PURIFICATION; MEDICAL RECORD; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOUTH KOREA; STOMACH; STOMACH NEOPLASMS; TIME FACTOR;

AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHI-SQUARE DISTRIBUTION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTON PUMP INHIBITORS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH; STOMACH NEOPLASMS; STOMACH ULCER; TIME FACTORS;

EID: 84928379933     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i16.4954     Document Type: Article

References (35)

1. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597-1604 [PMID: 20427808 DOI: 10.1056/NEJMcp1001110]
2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131 [PMID: 1891020 DOI: 10.1056/NEJM199110173251603]
3. Stewart BW, Kleihues P. World cancer report. Lyon: IARC Press, 2003:194
4. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling costeffectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996;348:150-154 [PMID: 8684154 DOI: 10.1016/S0140-6736 (96) 01501-2]
5. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-1252 [PMID: 8613015 DOI: 10.1053/gast.1996.v110.pm8613015]
6. Rosenstock S, Jørgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 2003;52:186-193 [PMID: 12524398 DOI: 10.1136/gut.52.2.186]
7. Hansson LE, Nyrén O, Hsing AW, Bergström R, Josefsson S, Chow WH, Fraumeni JF, Adami HO. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-249 [PMID: 8657240 DOI: 10.1056/NEJM199607253350404]
8. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789 [PMID: 11556297 DOI: 10.1056/NEJMoa001999]
9. Molloy RM, Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut 1997;40:247-252 [PMID: 9071940 DOI: 10.1136/gut.40.2.247]
10. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005;100:1037-1042 [PMID: 15842576 DOI: 10.1111/j.1572-0241.2005.41384.x]
11. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983-1991 [PMID: 9394739 DOI: 10.1016/S0016-5085 (97) 70019-2]
12. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-691 [PMID: 7657096 DOI: 10.1016/0016-5085 (95) 90374-7]
13. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615-625 [PMID: 2642447]
14. Lauwers G, Carneiro F, Graham DY, Curado MP, Franceschi S, Hattori T, Montgomery E, Tematsu M. Gastric Cancer. In: Bosman FT, Carnerio F, Hruban RF, Theise ND, editors. World Health Organization Classification of Tumours of the Digestive System. 4th ed. Lyon: IARC, 2010:48-58
15. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol 2010;45:1-8 [PMID: 19714291 DOI: 10.1007/s00535-009-0117-8]
16. Zhao L, Shen ZX, Luo HS, Yu JP. Clinical investigation on coexisting of duodenal ulcer and gastric cancer in China. Int J Clin Pract 2005;59:1153-1156 [PMID: 16178981 DOI: 10.1111/j.1368-5031.2005.00594.x]
17. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors. 6th ed. New York, NY: Wiley-Liss, 2002
18. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49 [PMID: 14320675]
19. Hamilton SR, Aaltonen LA, Editors. World Health Organization Classification of Tumours. Pathology and Genetics, Tumours of the Digestive System. Lyon, France: IARC Press, 2000
20. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1:10-24 [DOI: 10.1007/PL00011681]
21. De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607-615 [PMID: 22575588 DOI: 10.1016/S1470-2045 (12) 70137-7]
22. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993;341:1359-1362 [PMID: 8098787 DOI: 10.1016/0140-6736 (93) 90 938-D]
23. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179 [PMID: 9609753 DOI: 10.1016/S0016-5085 (98) 70422-6]
24. Hansson LR, Engstrand L, Nyrén O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885-888 [PMID: 7657118 DOI: 10.1016/0016-5085 (95) 90398-4]
25. Kamada T, Kurose H, Yamanaka Y, Manabe N, Kusunoki H, Shiotani A, Inoue K, Hata J, Matsumoto H, Akiyama T, Hirai T, Sadahira Y, Haruma K. Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan. Digestion 2012;85:256-260 [PMID: 22472851 DOI: 10.1159/000336352]
26. Tsugane S, Tei Y, Takahashi T, Watanabe S, Sugano K. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 1994;85:474-478 [PMID: 8014104 DOI: 10.1111/j.1349-7006.1994.tb02382.x]
27. González CA, López-Carrillo L. Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 2010;45:6-14 [PMID: 20030576 DOI: 10.3109/0 0365520903401959]
28. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis 2009;10:77-84 [PMID: 19426388 DOI: 10.1111/j.1751-2980.2009.00368.x]
29. Cheli R, Santi L, Ciancamerla G, Canciani G. A clinical and statistical follow-up study of atrophic gastritis. Am J Dig Dis 1973;18:1061-1065 [PMID: 4761527 DOI: 10.1007/BF01076522]
30. De Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, Van Grieken NC, Kuipers EJ. Epidemiological trends of premalignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007;56:1665-1670 [PMID: 17698860 DOI: 10.1136/gut.2007.127167]
31. You WC, Li J Y, Blot WJ, Chang YS, Jin ML, Gail MH, Zhang L, Liu WD, Ma JL, Hu YR, Mark SD, Correa P, Fraumeni JF, Xu GW. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615-619 [PMID: 10521796]
32. De Vries AC, Van Grieken NC, Looman CW, Casparie MK, De Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945-952 [PMID: 18395075 DOI: 10.1053/j.gastro.2008.01.071]
33. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740 [PMID: 1458460]
34. Meining A, Bayerdörffer E, Müller P, Miehlke S, Lehn N, Hölzel D, Hatz R, Stolte M. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-314 [PMID: 9565339 DOI: 10.1007/s004280050171]
35. Shimoyama T, Fukuda S, Tanaka M, Nakaji S, Munakata A. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori. Virchows Arch 2000;436:585-587 [PMID: 10917173 DOI: 10.1007/s004289900179]